Last reviewed · How we verify
NCT03355144: ROBSTA
Resident Observed Burnout After Daily Supplementation With Coffee
NA trial testing Daily Supplementation with Coffee in Burnout, Professional in 39 participants. Completed in 12 April 2018.
12 April 2018
Quick facts
| Lead sponsor | NYU Langone Health |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 39 |
| Start date | 22 March 2018 |
| Primary completion | 12 April 2018 |
| Estimated completion | 12 April 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Daily Supplementation with Coffee
Conditions studied
- Burnout, Professional — all drugs for Burnout, Professional →
Sponsor
NYU Langone Health — full company profile →
Who can join
Adults 18 to 80, any sex, with Burnout, Professional. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Coffee drinking is frequently reported as a negative outcome in studies on burnout, but the effect of an increased coffee intake on resident burnout has not been reported in the literature. This study is a prospective, interventional cohort study enrolling up to 50 residents from the Internal Medicine Residency Program to look at the relationship between coffee and resident burnout.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03355144
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Burnout, Professional
Currently open trials in the same condition.
- NCT07221422 — The PREGNANT (Pregnant Resident Empowerment, GuidaNce, and Advocacy iN Training) Coaching Project · NA · recruiting
- NCT07423468 — Developing Competency Awareness and Clinical Coordination in a Neonatal Unit · NA · active not recruiting
- NCT07262372 — Supervision in Substance Use Disorder Treatment Programs · NA · recruiting
- NCT07089160 — Decision Fatigue and Emotional Exhaustion Among Anesthesiologists · recruiting
- NCT05942469 — Fostering Optimal Regulation of Emotion for Prevention of Secondary Trauma (FOREST) · NA · recruiting
Other NYU Langone Health trials
Trials by the same sponsor.
- NCT07214519 — Permanent Supportive Housing Overdose Prevention-2 Study · NA · not yet recruiting
- NCT05558267 — Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease · NA · not yet recruiting
- NCT06637852 — Sexual and Urinary Function Improvement for Cancer Survivors · NA · not yet recruiting
- NCT06236087 — Overdose Prevention Centers and Behavioral Health · not yet recruiting
- NCT06462027 — Packed Red Blood Cell Transfusion During Cardiac Arrest · Phase 1 · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03355144 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NYU Langone Health
- Last refreshed: 22 May 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03355144.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing